Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans

Neuroendocrinology

Volumn 67, Issue 5, 1998, Pages 310-316

  Arvat, Emanuela ^a   Maccagno, Barbara ^a   Ramunni, Josefina ^a   Di Vito, Lidia ^a   Gianotti, Laura ^a   Broglio, Fabio ^a   Benso, Andrea ^a   Deghenghi, Romano ^b   Camanni, Franco ^b   Ghigo, Ezio ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

hydroxybutyric acid; Adrenal steroids; Benzodiazepines; Clinical neuroendocrinology; Corticotropin; Growth hormone; Growth hormone releasing peptides

Indexed keywords

ALPRAZOLAM; CORTICOTROPIN; DEXAMETHASONE; GROWTH HORMONE; HEXARELIN; HYDROCORTISONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALPRAZOLAM; DEXAMETHASONE; FEMALE; GABA MODULATORS; GLUCOCORTICOIDS; GROWTH SUBSTANCES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; OLIGOPEPTIDES; REFERENCE VALUES; SECRETORY RATE; STIMULATION, CHEMICAL;

EID: 0031961561     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054328     Document Type: Article

References (46)

1. Bowers CY, Veeraragavan K, Sethumadhavan K: Atpyical growth hormone releasing peptides; in Bereu BB, Waler RF (eds): Growth Hormone II. Basic and Clinical Aspects. New York, Springer, 1993, pp 203-222.
2. Ghigo E, Arvat E, Muccioli G, Camanni F: Growth hormone (GH)-releasing peptides. Eur J Endocrinol 1997;136:445-460.
3. DeVita RJ, Wyvratt MJ: Benzolactam growth hormone secretagogues. Drugs Future 1996;21: 273-281.
4. Deghenghi R: Growth hormone releasing peptides; in Bercu B, Walker R (eds): Growth Hormone Secretagogues. New York, Serono Symposia, 1993, pp 85-102.
5. Jacks T, Hickey G, Judith F, Taylor J, Chen H, Krupa D, Feeney W, Schoen W, Fisher M, Wyratt M, Smith R: Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. J Endocrinol 1994;143: 399-406.
6. Korbonits M, Trainer PJ, Besser GM: The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin Endocrinol 1995;43:365-371.
7. Arvat E, Di Vito L, Maccagno B, Broglio E, Boghen ME, Deghenghi R, Camanni E, Ghigo E: Effects of GHRP-2 and Hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol level in man. Comparison with the effects of GHRH, TRH, and hCRH. Peptides 1997;18:885-891.
8. Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F: Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J Clin Endocrinol Metab 1997;82:2439-2444.
9. Thomas GB, Fairhall KM, Robinson ICAF: Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue GH-releasing peptide-6, in rats. Endocrinology 1997;138:1585-1591.
10. Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E: Hexarelin, a synthetic GH-releasing peptide, shows no interaction with CRH and vasopressin on ACTH and cortisol secretion in humans. Neuroendocrinology 1997;66:432-438.
11. Muccioli G, Ghè C, Ghigo MC, Arvat E, Papotti M, Boghen MF, Dehenghi R, Ong H, Ghigo E: Growth hormone-releasing peptide receptors in human brain and pituitary gland. Fundam Clin Pharmacol 1996;10(suppl):205.
12. Pong SS, Chaung LYP, Dean DC, Nargunt RP, Patchett AA, Smith RG: Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10: 57-61.
13. Howard AD, Feighner Sd, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Uamelin M, Ureniuk DL, Palyhe OC, Anderson J, Paress PS, Diaz C, Chou N, Liu KK, McKee KK, Pong SS, Cheung LY, Elbrecht A, Dashkevicz M, Keavehs R, Rish M, Siringjhsinghji DJS, Dena DC, Melillo DG, Patchett AA, Nergund R, Srillin PR: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977.
14. Bowers CY, Sartor AO, Reynolds GA, Badger TM: On the action of the growth hormone-releasing hexapeptides, GHRP. Endocrinology 1991;128:2027-2035.
15. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF: Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 1995;80:942-947.
16. Dickson SL, Luckman SM: Induction of c-fos messenger ribonucleic acid in neuropeptide Y growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997;138:771-777.
17. Goth MI, Lyons CE, Canny BY, Thorner MO: Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992;130:939-944.
18. Fairhall KM, Mynett A, Robinson ICAF: Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 1995;144:555-560.
19. Hickey GJ, Drisko J, Faidley T, Chang C, Anderson L, Nicolich S, McGuire L, Riches E, Krupe D, Feeney W, Friscino R, Cunninghan P, Frazier E, Chen H, Leroque P, Smith RG: Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 1996;148:371-380.
20. Loche S, Cambiaso P, Merola B, Colao A, FaeddaA, Imbimbo BP: The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J Clin Endocrinol Metab 1995;80:2692-2969.
21. Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, Deghenghi R, Camanni F, Ghigo E: Metabolic modulation of the growth-hormone-releasing activity of hexarelin in man. Metabolism 1995;44:134-138.
22. Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R, Ghigo E: Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 1995; 61:51-56.
23. Giustina A, Bussi AR, Deghenghi R, Imbimbo BP, Licini M, Poiesi C, Wehrenberg WB: Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess. J Endocrinol 1995;146:227-232.
24. Gertz BJ, Sciberras DG, Yogendran L, Christie K, Bador K, Krupa D, Wittreich JM, James I: L-692,429, a non peptide growth hormone (GH) secretagogue reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 1994;79:745-749.
25. Massoud AF, Hindmrsh PC, Brook CG: Hexarelin induced growth hormone release is influenced by exogenous growth hormone. Clin Endocrinol 1995;43:617-621.
26. Arvat E, Di Vito L, Gianotti L, Ramunni J, Boghen MF, Deghenghi R, Camanni F, Ghigo E: Mechanism underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Metabolism 1997;46:83-88.
27. Rhorer T, von Richthofen V, Schulz C, Beyer J, Lehnert H: The stress, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam. Horm Metab Res 1993;26:200-206.
28. Torpy DJ, Grice EJ, Hockings GI, Walters MM, Crosbie GV, Jackson RV: Alprazolam blocks the naloxone-stimulated hypothalamopituitary-adrenal axis in man. J Clin Endocrinol Metab 1993;76:388-391.
29. Torpy DJ, Grice EJ, Hockings GI, Walters MM, Crosbie GV, Jackson RV: Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: Evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. J Clin Endocrinol Metab 1994;79:140-144.
30. Dieguez C, Mallo F, Senaris R, Pineda J, Martul P, Leal-Cerro A, Pombo M, Casanueva FF: Role of glucocorticoids in the neuroregulation of growth hormone secretion. J Pediatr Endocrinol Metab 1996;9:225-260.
31. Casanueva FF, Burguera B, Muruais C, Dieguez C: Acute administration of corticoids: A new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 1990;70:234-237.
32. Risby ED, Hsiao JK, Golden RN, Potter WZ: Intravenous alprazolam challenge in normal subjects, biochemical, cardiovascular and behavioural effects. Psychopharmacology 1989; 99:508-514.
33. Orth DN: Corticotropin-releasing hormone in humans. Endocr Rev 1992;13:164-191.
34. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO: Enhancement of pulsatile growth hormone secretion by continuous infusion of growth hormone-releasing peptide mimetic, L-692,429, in older adults. A clinical research center study. J Clin Endocrinol Metab 1996;81: 2874-2880.
35. Copinschi G, van Onderbergen A, L'hermite-Baleriaux M, Mendel CM, Caufriez A, Leproult R, Bolognese JA, De Smet M, Thorner MO, van Cauter E: Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J Clin Endocrinol Metab 1996;81:2776-2782.
36. De Keyzer Y, Lenne F, Bertagna X: Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors. Eur J Endocrinol 1997; 137:715-718.
37. Jackson RV, Grice JE, Hockings GI, Torpy DJ: Naloxone-induced ACTH release: Mechanism of action in humans. Clin Endocrinol 1995;43: 423-424.
38. Kaolgeras KT, Calogero AE, Kuribayiashi T: In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamicpituitary-adrenal function: Pharmacological and clinical implication. J Clin Endocrinol Metab 1990;70:1462-1471.
39. Breier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D, Goldstein DS: Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biol Psychiatry 1992;32:880-890.
40. Eriksson E, Carlsson M, Nilsson C, Soderpalm B: Does alprazolam, in contrast to diazepam, activate alpha-2-adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986;39:1491-1498.
41. Plotsky PM, Cunningham ET Jr, Widmaier EP: Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 1989;10:437-502.
42. Muller EE, Nisticò G (eds): Brain Messenger and the Pituitary. San Diego, Academic Press, 1989.
43. Arvat E, Maccagno B, Ramunni J, Gianotti L, Di Vito L, Deghenghi R, Camanni F, Ghigo E: Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man. J Endocrinol Invest 1997;20:122-127.
44. Leal Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF: Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol 1994;41:649-654.
45. Zemishlany Z, McQueeney R, Gabriel SM, Davidson M: Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects. Neuropsychobiology 1990;23:124-128.
46. Cavagnini F, Invitti C, Pinto M, Maraschini C, Di Landro A, Dubini A, Marelli A: Effect of acute and repeated administration of gamma-aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta Endocrinol 1980;93:149-154.